Among these six genes, ANG, IL1A, LOXL1, LOXL2, and STEAP3 played risk roles in the survival of glioma patients (HR > 1), while F5 was a potential protective factor (HR < 1). This evidence concerns the gene STEAP3 and central nervous system cancer.